David S Snyder insider trades

Open-market stock purchases and sales by David S Snyder, Chief Financial Officer at Coya Therapeutics, Inc, from SEC Form 4 filings since Jul 30, 2013.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +20%.

Recent trades

DateStockTradeValue
Jan 22, 2026COYA Coya Therapeutics, IncBought (not open market)—

Companies traded

  • COYA Coya Therapeutics, Inc: 3 buys, last Jan 22, 2026
  • XCUR Exicure, Inc: 1 buy, last Mar 13, 2020
  • ICEL Cellular Dynamics International, Inc: other filings, last Mar 6, 2014

Get free alerts when David S Snyder files a new trade →